The webinar will feature a presentation from Key Opinion Leader (KOL) Cynthia A. Lemere, Ph.D., of the Ann Romney Center for Neurologic Diseases at Brigham & Women’s Hospital.

During her presentation, Dr. Lemere will discuss the current immunotherapy landscape and novel therapeutic approaches to treat and prevent neurodegenerative diseases, with a focus on biomarkers and target proteins for active vaccination approaches.

Additionally, members of AC Immune’s management team will provide an overview of the Company’s precision medicine approach, industry-leading pipeline of active vaccines, and the advantages offered by the innovative biomarker-based clinical trial designs being utilized in its Alzheimer’s and Parkinson’s disease programs.

A live question and answer session will follow the formal presentations.